Company / Income Tax
Monte Rosa Therapeutics, Inc. Income Tax History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.6M
FY2024
5-year range
$0 / $2.6M
FY2022-FY2024
Trend
+660.4%
vs FY2023
Sector context
#59 of 204
Health Care
What the data says
At $3M, Monte Rosa Therapeutics, Inc.'s income tax ranks #146 of 204 in the Health Care sector. Increased from $0 to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2024.
Increased from $0 to $3M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#146 of 204 in Health CareTop 71% of 204This company $2.6M Sector average $118.7M
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2024, income tax increased 660.4% year-over-year.
- Ranks #59 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.6M | +660.4% |
| FY2023 | $338.0K | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026